EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, APLS: Apellis Pharmaceuticals Inc

13 Mar 26 15:59
LAST:

18.95

CHANGE:
 0.55		OPEN:
18.57		HIGH:
19.05		ASK:
0.00		VOLUME:
805.4K
CHG(%):
2.99		PREV:
18.39		LOW:
18.42		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
13 Mar 2618.8419.0518.4218.941.72M
12 Mar 2619.2619.2618.3318.392.6M
11 Mar 2619.4319.4918.9819.381.65M
10 Mar 2619.8920.0119.4119.641.33M
09 Mar 2620.0020.2019.3319.991.66M
06 Mar 2620.2120.3919.7520.071.63M
05 Mar 2620.0920.8019.8320.152.93M
04 Mar 2620.3220.3219.5519.862.88M
03 Mar 2620.4920.6220.0220.161.41M
02 Mar 2620.3321.0020.1220.701.63M

PROFILE

Name:Apellis Pharmaceuticals Inc
About:Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria; and SYFOVRE for treating geographic atrophy secondary to age-related macular degeneration and geographic atrophy (GA). The company also develops EMPAVELI to treat C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, hematopoietic stem cell transplantation-associated thrombotic microangiopathy, focal segmental glomerulosclerosis, and delayed graft function; and APL-3007, a small interfering RNA, or siRNA for the treatment of GA. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) for development and commercialization of pegcetacoplan; and a collaboration with Beam Therapeutics Inc. focused on the use of Beam's base editing technology to discover new treatments for complement-driven diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:100 Fifth Avenue, Waltham, MA, United States, 02451
Website:https://apellis.com
CUSIP:03753U106
CIK:0001492242
ISIN:US03753U1060
FIGI:BBG007KGRPY4
LEI:254900HS0ZFRXXSB9D42

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:73.58 
Forward P/E:-22.84 
Price to Sales:3.98 
Price to Book:8.35 
EPS Ratio:0.36 
Revenue:754.65M 
Shares:126.53M 
Market Cap:2.398B 

TECHNICAL INDICATORS

MA5:19.271.7%
MA10:19.734.1%
MA20:20.829.9%
MA50:22.0916.6%
MA100:22.6419.5%
MA200:22.4818.6%
STO9:22.82
STO14:12.85 
RSI14:18.76 
WPR14:-85.29 
MTM14:-3.19
ROC14:-0.14 
ATR:1.00 
Week High:20.397.6%
Week Low:18.333.4%
Month High:22.8120.4%
Month Low:18.3318.6%
Year High:30.4860.8%
Year Low:16.1017.7%
Volatility:20.20